wayground logo

Free Printable Worksheets

NEW

Font size

S
M
L
XL
Worksheets

SLMC RTD Post-Quiz

Total questions: 10

Worksheet time: 3mins

Name
Class
Date
1.

45M diagnosed with Stage IV Classical Hodgkin Lymphoma presented with the following Lab results:

Hgb: 9.0 ; WBC 15000 ; Lymphocyte 700 cells/microL

Serum albumin 5g/dL

What is the International Prognostic score?

a)

3

b)

4

c)

5

d)

6

2.

The Deauville Score if the uptake in FDG-PET is markedly higher than liver (ie, two to three times the maximum SUV in the liver) and/or new lesions:

a)

3

b)

4

c)

5

d)

6

3.

According to the European Organization for the Research and Treatment of Cancer (EORTC), all of the following are unfavorable prognostic factors in early stage (stage I/II) Hodgkin Lymphoma except:

a)

Large mediastinal adenopathy (>1/3 maximum transverse thoracic diameter)

b)

Involvement of four or more lymph node regions

c)

Age <50 years at diagnosis

d)

defined combination of B symptoms* and elevated ESR

4.

If patient presented with involvement of two or more lymph node regions on the same side of the diaphragm alone or with involvement of limited, contiguous extralymphatic organ or tissue.

What is the Stage of cHL based on the Lugano Classification

a)

I

b)

II

c)

III

d)

IV

5.

All of the following statements are true regarding hepatic damage in cHL except:

a)

50% of the time is nonspecific inflammation at portal areas

b)

uncommon at diagnosis

c)

hepatic damage increases as disease progresses

d)

Acute liver failure is common at presentation

6.

Jaundice is a common presentation in Hodgkin Lymphoma with Hepatic Damage

a)

True

b)

False

7.

A core biopsy of liver is required for confirmation of hepatic infiltration in cHL with Liver involvement

a)

True

b)

False

8.

Which of the following components of the ABVD Regimen is excreted both via the Renal and Hepatic route:

a)

Doxorubicin

b)

Bleomycin

c)

Vinblastine

d)

Dacarbazine

9.

This component of the ABVD regimen can be safely given in patients with liver failure because it is renally excreted:

a)

Doxorubicin

b)

Bleomycin

c)

Vinblastine

d)

Dacarbazine

10.

All of the following regimens can be safely given in patients with cHL with Liver Failure as bridging therapy except:

a)

CEPP

b)

Gemcitabine

c)

BEACOPP

d)

Brentuximab